Follow Medasense’s accomplishments and news

PMD-200™ and the NOL index are commercially available in Australia!

NOL in Australia:
We are happy to share with you that Medasense received approval to market the PMD-200™ system in Australia, strengthening commercial presence around the world.

The PMD-200™ and its NOL® index are currently commercially available in Europe, Canada, Australia and Israel.

Please note that it is not commercially available yet in the USA.

Video Highlights

The essence of Medasense: Guiding critical care clinicians for optimal pain care

Meeting the challenge of intraoperative pain monitoring

Leading clinicians on the importance of monitoring the patient’s pain response level